ArticleNature communications2019

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.

Yibo Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.